PRS21 ANALYSIS OF CLINICAL EFFICACY AND DIRECT COSTS OF THE SPECIFIC IMMUNOTHERAPY IN POLAND-A THREE-YEAR RETROSPECTIVE STUDY
Abstract
Authors
KM Jahnz-Roozyk T Targowski P Przekora
KM Jahnz-Roozyk T Targowski P Przekora
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now